Continuing Education (Courses)


Pharmacotherapy (by disease module)

  • PHAR5711 Course in Pharmacotherapy: Special Populations
  • PHAR5712 Course in Pharmacotherapy: Hospital Care
  • PHAR5713 Course in Pharmacotherapy: Community Care
  • PHAR5714 Course in Pharmacotherapy: Infectious Diseases
  • PHAR5715 Course in Pharmacotherapy: Cardiovascular Disorders
  • PHAR5716 Course in Pharmacotherapy: Oncologic Disorders
  • PHAR5717 Course in Pharmacotherapy: Respiratory Disorders
  • PHAR5718 Course in Pharmacotherapy: Dermatologic Disorders
  • PHAR5719 Course in Pharmacotherapy: Psychiatric Disorders
  • PHAR5720 Course in Pharmacotherapy: Diabetes and Renal Disorders
  • PHAR5721 Course in Pharmacotherapy: Gastrointestinal Disorders
  • PHAR5722 Course in Pharmacotherapy: Bone and Joint Disorders
  • PHAR5852 Course in Pharmacovigilance and Public Health for Pharmacist

Clinical Pharmacy Skills

Clinical Pharmacy Skills

  • PHAR5731 Course in Clinical Pharmacy Skills: Research Methodology and Statistics
  • PHAR5732 Course in Clinical Pharmacy Skills: Drug Information and Literature Evaluation
  • PHAR5733 Course in Clinical Pharmacy Skills: Drug Therapy and Patient Assessment

Medication Management

Medication Management (Geriatric Care)

  • PHAR 7100 Course in Medication Management (Geriatric Care)


Specialty Training

Advanced Courses in Specialty Training

Open for Application

Date of Offer: 2019

Course Number & Title: PHAR 5950 Advanced Course in Specialty Training of Oncology Pharmacist
Course Description: The course is designed to provide pharmacists with the knowledge and skills needed for medication management in cancer patients. After attending this certificate course, students should be able to:

  • Devise and communicate appropriate plans for preventing, monitoring and treating adverse reactions associated with treatment of cancers.
  • Devise and communicate appropriate plans for treating cancer-related complications, eg. cancer pain, tumor lysis syndrome, etc.
  • Apply general dosing and dose modifications for anticancer drugs in patients with renal and hepatic dysfunction.
  • Detect and advise on the management of potential drug interactions, especially with the targeted therapy.
  • Outline the appropriate pharmacologic and non-pharmacologic treatment of various types of cancer common in Hong Kong.
  • Explain expected outcomes to a given therapeutic modality in terms of response, survival, and toxicity.
  • Provide input in protocol development.
Fee per Course: HKD $25,000
Unit of Study: 5 units
Language of Instruction: English
Course Assessment: 50%: Multiple choice examination: 100 Qs 

50%: Case work-up

  • Passing grade is 60% on the written examination.
  • Overall grade will be stated on the transcript.
Certificate: A Certificate of Completion will be issued to students who have achieved an 80% attendance and passed the written examination (Passing grade: 60%). For students who achieved an 80% attendance but not passing the written examination, a Certificate of Attendance will be issued.


Date and Time: Jul 29- Aug 2, 2019

Nov 21-29, 2019

Venue: CUHK, Princess Margaret Hospital, Queen Elizabeth Hospital & Princes of Wale Hospital
Detailed timetable will be sent to registered students in due course.

Speaker Information

Alexandre Chan, PharmD, MPH, BCPS, BCOP

Tenured Associate Professor with the Department of Pharmacy at National University of Singapore

Associate Consultant Clinical Pharmacist at National Cancer Centre Singapore


Betty Mei-Chu Chan, PharmD, BCOP

Assistant Professor of Clinical Pharmacy at University of Southern California (USC) School of Pharmacy

Pharmacy Practice Residency Program Director and Preceptor at Norris Comprehensive Cancer Center and Hospital


Dr. Alexandre Chan is a tenured Associate Professor with the Department of Pharmacy at National University of Singapore and an Associate Consultant Clinical Pharmacist at National Cancer Centre Singapore. He completed his Doctor of Pharmacy at Rutgers University, and subsequently, a Pharmacy Practice Residency at University of California San Francisco and an Oncology Specialty Residency at University of California Davis Medical Center. He has also completed his Master of Public Health at National University of Singapore. He is currently certified by the US Board of Pharmaceutical Specialties as Board Certified Pharmacotherapy Specialist and Board Certified Oncology Pharmacist. Dr. Chan’s clinical and research portfolio includes oncology supportive care (in lymphoma and breast cancer patients), anticancer drug-drug interactions and associated toxicities, and pharmacoepidemiology. He has published over 60 full-length peer-reviewed manuscripts in various medical and pharmacy journals, including Journal of Clinical Oncology, Lancet Oncology, Annals of Oncology, Pharmacoepidemiology and Drug Safety, Supportive Care in Cancer, Clinical Therapeutics and Annals of Pharmacotherapy. Dr. Chan has received numerous grants and awards for his research, and has delivered lectures at numerous regional and international oncology and pharmacy conferences. Dr. Betty Chan received her Doctor of Pharmacy degree from the University of Southern California (USC) in 1993.  She then completed a one-year post-doctoral Pharmacy Practice Residency training at Cedars-Sinai Medical Center in 1994, and an additional one-year specialty residency in Hematology-Oncology at the University of California, San Francisco (UCSF) in 1995.  Dr. Chan has worked as a Clinical Pharmacist in the Hematology-Oncology/Bone Marrow & Stem Cell Transplantation Unit at Cedars –Sinai Medical Center and as Clinical Pharmacist at the UCLA/Jonnson Comprehensive Cancer Center before joining the faculty members at the USC School of Pharmacy in May 2001.  Dr. Chan is an Assistant Professor of Clinical Pharmacy at USC School of Pharmacy, and is also Pharmacy Practice Residency Program Director and Preceptor at Norris Comprehensive Cancer Center and Hospital since 2003.  She is actively involved in providing daily patient care and clinical services to Hematology-Oncology patients in the Ambulatory Care setting.  Dr. Chan serves as clerkship preceptor to Level IV pharmacy students and teaches didactic lectures in the Oncology Therapeutics Module and has been the Oncology Therapeutics Module Course Co-coordinator since 2007.  Dr. Chan has been board-certified by the Board of Pharmaceutical Specialties (US) in Oncology since December 2002, and has recently been re-certified in July 2009.

Admission Requirements

Applicants should possess

  • A Bachelor degree in pharmacy or higher AND
  • 4 years practice experience with minimal 3 years of relevant working experience*
  • Nomination by Department Manager/ department in-charge

* Relevant working experience includes provision of pharmacy service to oncology patients and chemotherapy reconstitution service

Application Method

Applicants should complete both Step 1 and 2.

Step 1
Apply online through the link of online registration and upload the following supporting documents:

A copy of HK identity card

A copy of Bachelor of Pharmacy graduation certificate

Step 2
Mail the crossed cheque payable to “The Chinese University of Hong Kong” to the School of Pharmacy within 3 working days. Please quote your application no. “PHAR5950-X” at the back of the cheque and on the envelope.

Application Deadline

July 5th, 2019 (Applications received after deadline will only be considered if vacancy allowed.)


Please feel free to contact us for further enquiry about the program.

Address: School of Pharmacy
8th Floor, Lo Kwee-Seong Integrated Biomedical Sciences Building
Area 39, The Chinese University of Hong Kong
Shatin, N.T., Hong Kong
Tel: 3943-6862
Fax: 2603-5295

Comments are closed